Completed NA INTERVENTIONAL 2-arm NCT03644966

Probiotics and Multi-Drug Resistant Urinary Tract Infection

Probiotic and Effects on Multi-Drug Resistant Urinary Tract Infection

Sponsor: Ochsner Health System

Conditions Antibiotic Resistant Infection Recurrent UTI Urinary Tract Infections

Interventions Antibiotics Bifidobacterium infantis Placebo

Updated 6 times since 2018 Last updated: Apr 10, 2023 Started: Jul 5, 2018 Primary completion: Dec 15, 2022 Completion: Dec 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03644966, this NA trial focuses on Antibiotic Resistant Infection and Recurrent UTI and remains completed. Sponsored by Ochsner Health System, it has been updated 6 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — May 2023 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Sep 2018 — Sep 2020 [monthly]

Recruiting NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ochsner Health System
Procter and Gamble

Data source: Ochsner Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jefferson, United States